XSAT:CSMED (Denmark)
Â
Unit (5 Ord Shares & 2 Wrts Ser 1)
kr
3.70
(+8.19%)
Jul 4
Business Description
CS Medica AS
ISIN : DK0061668225
Share Class Description:
XSAT:CSMED: Unit (5 Ord Shares & 2 Wrts Ser 1)Compare
Compare
Traded in other countries / regions
CSMED.Sweden8G8.Germany IPO Date
2021-09-14Description
CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis. It operates in two business segments such as GalaxaPharma A/S responsible for distribution operation for marketing and sales direct-to-consumer, to retailers, and e-tail and CANNORDIC A/S is engaged in research and development, establishing of global business contracts, supply of CBD ingredients and production of finished products.
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.15 | |||||
Debt-to-Equity | 2.29 | |||||
Debt-to-EBITDA | -0.82 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.19 | |||||
Beneish M-Score | -4.99 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.5 | |||||
3-Year EPS without NRI Growth Rate | -518 | |||||
3-Year FCF Growth Rate | -90.4 | |||||
3-Year Book Growth Rate | 372.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 69.58 | |||||
9-Day RSI | 60.32 | |||||
14-Day RSI | 55.24 | |||||
6-1 Month Momentum % | -5.43 | |||||
12-1 Month Momentum % | -45.56 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.34 | |||||
Quick Ratio | 0.17 | |||||
Days Inventory | 313.27 | |||||
Days Sales Outstanding | 220.97 | |||||
Days Payable | 673.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.2 | |||||
Shareholder Yield % | -15.06 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.58 | |||||
Operating Margin % | -313.69 | |||||
Net Margin % | -268.44 | |||||
FCF Margin % | -101.08 | |||||
ROE % | -121 | |||||
ROA % | -46.5 | |||||
ROIC % | -47.83 | |||||
ROC (Joel Greenblatt) % | -463.79 | |||||
ROCE % | -78.54 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.05 | |||||
PB Ratio | 8.01 | |||||
EV-to-EBIT | -3.6 | |||||
EV-to-EBITDA | -4.15 | |||||
EV-to-Revenue | 11.63 | |||||
EV-to-FCF | -9.91 | |||||
Earnings Yield (Greenblatt) % | -27.78 | |||||
FCF Yield % | -10.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CS Medica AS Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 4.886 | ||
EPS (TTM) (kr) | -1.064 | ||
Beta | 0 | ||
Volatility % | 109.37 | ||
14-Day RSI | 55.24 | ||
14-Day ATR (kr) | 0.519747 | ||
20-Day SMA (kr) | 3.298 | ||
12-1 Month Momentum % | -45.56 | ||
52-Week Range (kr) | 2.01 - 6.26 | ||
Shares Outstanding (Mil) | 12.32 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CS Medica AS Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CS Medica AS Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
CS Medica AS Frequently Asked Questions
What is CS Medica AS(XSAT:CSMED)'s stock price today?
The current price of XSAT:CSMED is kr3.70. The 52 week high of XSAT:CSMED is kr6.26 and 52 week low is kr2.01.
When is next earnings date of CS Medica AS(XSAT:CSMED)?
The next earnings date of CS Medica AS(XSAT:CSMED) is 2024-08-16.
Does CS Medica AS(XSAT:CSMED) pay dividends? If so, how much?
CS Medica AS(XSAT:CSMED) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |